Novadaq Technologies Inc. (TSE:NDQ)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Wedbush in a research note issued to investors on Thursday. They presently have a C$17.00 target price on the stock.
Separately, Royal Bank Of Canada restated an “outperform” rating on shares of Novadaq Technologies in a research report on Thursday, July 7th.
Novadaq Technologies (TSE:NDQ) opened at 14.62 on Thursday. The company’s market cap is $839.70 million. Novadaq Technologies has a 12-month low of $10.81 and a 12-month high of $20.40. The stock’s 50 day moving average price is $15.45 and its 200 day moving average price is $13.99.
About Novadaq Technologies
Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.
Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.